Slinin Y, Foley RN, Collins AJ (2005) Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: the USRDS waves 1, 3, and 4 study. J Am Soc Nephrol 16:1788–1793. https://doi.org/10.1681/asn.2004040275

Article  CAS  PubMed  Google Scholar 

Young EW, Albert JM, Satayathum S et al (2005) Predictors and consequences of altered mineral metabolism: the dialysis outcomes and practice patterns study. Kidney Int 67:1179–1187. https://doi.org/10.1111/j.1523-1755.2005.00185.x

Article  CAS  PubMed  Google Scholar 

Melamed ML, Eustace JA, Plantinga L et al (2006) Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: a longitudinal study. Kidney Int 70:351–357. https://doi.org/10.1038/sj.ki.5001542

Article  CAS  PubMed  Google Scholar 

Komaba H, Zhao J, Yamamoto S et al (2021) Secondary hyperparathyroidism, weight loss, and longer term mortality in haemodialysis patients: results from the DOPPS. J Cachexia Sarcopenia Muscle 12:855–865. https://doi.org/10.1002/jcsm.12722

Article  PubMed  PubMed Central  Google Scholar 

Bozic M, Diaz-Tocados JM, Bermudez-Lopez M et al (2022) Independent effects of secondary hyperparathyroidism and hyperphosphataemia on chronic kidney disease progression and cardiovascular events: an analysis from the NEFRONA cohort. Nephrol Dial Transpl 37:663–672. https://doi.org/10.1093/ndt/gfab184

Article  CAS  Google Scholar 

Jain N, Bansal R, Saxena S, Sharma S, Raju SB (2024) Predictors of functional impairment and mortality in patients on maintenance hemodialysis. Semin Dial 37:138–144. https://doi.org/10.1111/sdi.13173

Article  PubMed  Google Scholar 

Liu CT, Lin YC, Lin YC et al (2017) Roles of serum calcium, phosphorus, PTH and ALP on mortality in peritoneal dialysis patients: a nationwide, population-based longitudinal study using TWRDS 2005–2012. Sci Rep 7:33. https://doi.org/10.1038/s41598-017-00080-4

Article  CAS  PubMed  PubMed Central  Google Scholar 

Avram MM, Mittman N, Myint MM, Fein P (2001) Importance of low serum intact parathyroid hormone as a predictor of mortality in hemodialysis and peritoneal dialysis patients: 14 years of prospective observation. Am J Kidney Dis 38:1351–1357. https://doi.org/10.1053/ajkd.2001.29254

Article  CAS  PubMed  Google Scholar 

Jean G, Lataillade D, Genet L et al (2011) Association between very low PTH levels and poor survival rates in haemodialysis patients: results from the French ARNOS cohort. Nephron Clin Pract 118:c211-216. https://doi.org/10.1159/000321642

Article  CAS  PubMed  Google Scholar 

Hong YA, Kim JH, Kim YK et al (2020) Low parathyroid hormone level predicts infection-related mortality in incident dialysis patients: a prospective cohort study. Korean J Intern Med 35:160–170. https://doi.org/10.3904/kjim.2018.264

Article  CAS  PubMed  Google Scholar 

Chen Z, Zhang X, Han F et al (2021) High alkaline phosphatase and low intact parathyroid hormone associate with worse clinical outcome in peritoneal dialysis patients. Perit Dial Int 41:236–243. https://doi.org/10.1177/0896860820918131

Article  CAS  PubMed  Google Scholar 

Kalantar-Zadeh K, Kuwae N, Regidor DL et al (2006) Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int 70:771–780. https://doi.org/10.1038/sj.ki.5001514

Article  CAS  PubMed  Google Scholar 

Fernández-Martín JL, Martínez-Camblor P, Dionisi MP et al (2015) Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS study. Nephrol Dial Transpl 30:1542–1551. https://doi.org/10.1093/ndt/gfv099

Article  CAS  Google Scholar 

Naves-Díaz M, Passlick-Deetjen J, Guinsburg A et al (2011) Calcium, phosphorus, PTH and death rates in a large sample of dialysis patients from Latin America. CORES Study Nephrol Dial Transpl 26:1938–1947. https://doi.org/10.1093/ndt/gfq304

Article  CAS  Google Scholar 

Zhou X, Guo Y, Luo Y (2021) The optimal range of serum intact parathyroid hormone for a lower risk of mortality in the incident hemodialysis patients. Ren Fail 43:599–605. https://doi.org/10.1080/0886022x.2021.1903927

Article  CAS  PubMed  PubMed Central  Google Scholar 

Floege J, Kim J, Ireland E et al (2011) Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population. Nephrol Dial Transpl 26:1948–1955. https://doi.org/10.1093/ndt/gfq219

Article  CAS  Google Scholar 

Lamina C, Kronenberg F, Stenvinkel P et al (2020) Association of changes in bone mineral parameters with mortality in haemodialysis patients: insights from the ARO cohort. Nephrol Dial Transpl 35:478–487. https://doi.org/10.1093/ndt/gfz060

Article  CAS  Google Scholar 

Rhee CM, Molnar MZ, Lau WL et al (2014) Comparative mortality-predictability using alkaline phosphatase and parathyroid hormone in patients on peritoneal dialysis and hemodialysis. Perit Dial Int 34:732–748. https://doi.org/10.3747/pdi.2013.00110

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tangri N, Wagner M, Griffith JL et al (2011) Effect of bone mineral guideline target achievement on mortality in incident dialysis patients: an analysis of the United Kingdom Renal Registry. Am J Kidney Dis 57:415–421. https://doi.org/10.1053/j.ajkd.2010.08.037

Article  PubMed  Google Scholar 

Palmer SC, Hayen A, Macaskill P et al (2011) Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis. JAMA 305:1119–1127. https://doi.org/10.1001/jama.2011.308

Article  CAS  PubMed  Google Scholar 

Guo W, Zhang H, Zhang Y, Huang H, Liu W, Diao Z (2022) Low parathyroid hormone versus secondary hyperparathyroidism and survival in patients undergoing hemodialysis: a propensity-matched analysis. Front Endocrinol (Lausanne) 13:869330. https://doi.org/10.3389/fendo.2022.869330

Article  PubMed  Google Scholar 

Tentori F, Blayney MJ, Albert JM et al (2008) Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the dialysis outcomes and practice patterns study (DOPPS). Am J Kidney Dis 52:519–530. https://doi.org/10.1053/j.ajkd.2008.03.020

Article  CAS  PubMed  Google Scholar 

Xi QP, Xie XS, Zhang L et al (2017) Impact of different levels of iPTH on all-cause mortality in dialysis patients with secondary hyperparathyroidism after parathyroidectomy. Biomed Res Int 2017:6934706. https://doi.org/10.1155/2017/6934706

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tentori F, Wang M, Bieber BA et al (2015) Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study. Clin J Am Soc Nephrol 10:98–109. https://doi.org/10.2215/cjn.12941213

Article  CAS  PubMed  Google Scholar 

Chen L, Tang X, Zheng H et al (2022) Optimal targets of chronic kidney disease-mineral and bone disorder markers for Chinese patients with maintenance peritoneal dialysis: a single-center retrospective cohort study. Ren Fail 44:336–345. https://doi.org/10.1080/0886022x.2022.2041438

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rhee H, Song SH, Kwak IS et al (2012) Persistently low intact parathyroid hormone levels predict a progression of aortic arch calcification in incident hemodialysis patients. Clin Exp Nephrol 16:433–441. https://doi.org/10.1007/s10157-011-0577-z

Article  CAS  PubMed  Google Scholar 

Cozzolino M, Brancaccio D, Cannella G et al (2012) VDRA therapy is associated with improved survival in dialysis patients with serum intact PTH ≤ 150 pg/mL: results of the Italian FARO Survey. Nephrol Dial Transpl 27:3588–3594. https://doi.org/10.1093/ndt/gfs108

Article  CAS  Google Scholar 

Yu Y, Diao Z, Wang Y, Zhou P, Ding R, Liu W (2020) Hemodialysis patients with low serum parathyroid hormone levels have a poorer prognosis than those with secondary hyperparathyroidism. Ther Adv Endocrinol Metab 11:2042018820958322. https://doi.org/10.1177/2042018820958322

Article  CAS